Form 4: Performant Healthcare Acquired for $7.75/Share

Performant Healthcare Inc. director Eric Yanagi reports the disposition of shares and restricted stock units on October 21, 2025, due to the company's acquisition by Continental Buyer, Inc. for $7.75 per share.

Summary

• Performant Healthcare Inc. is being acquired by Continental Buyer, Inc. through a merger, as per an Agreement and Plan of Merger dated July 31, 2025.
• The merger's effective date and the transaction date for the reported dispositions is October 21, 2025.
• Each share of Performant Healthcare Common Stock issued and outstanding immediately prior to the effective time of the merger was canceled and converted into the right to receive $7.75 in cash.
• Restricted Stock Units (RSUs) were also canceled for a lump sum cash payment equal to the total number of underlying shares multiplied by the $7.75 merger consideration.
• Director Eric Yanagi reported the disposition of 3,261,675 common shares and the cancellation of 381,835 RSUs as a result of this merger.

Sentiment

Score: 7

Explanation: The filing reports a definitive merger agreement with a clear cash payout, which provides certainty for shareholders. While it removes future upside, the fixed cash consideration is a positive for liquidity and risk reduction. The transaction is a planned event, not a surprise negative.

Positives

• Shareholders receive a definitive cash payment of $7.75 per share, providing liquidity and a clear return on investment.
• The merger provides a clear exit strategy for investors, eliminating market uncertainty regarding future performance.

Negatives

• Performant Healthcare Inc. will cease to be an independent publicly traded entity, removing future growth potential for existing shareholders.
• Shareholders will no longer participate in any potential upside beyond the $7.75 per share merger consideration.

Risks

• The merger consideration is subject to any applicable withholding taxes as provided in the Merger Agreement.
• The completion of the merger is contingent on the 'Effective Time' as defined in the Merger Agreement, implying potential for unforeseen delays or non-completion if conditions are not met.

Future Outlook

Performant Healthcare Inc. will become a wholly-owned subsidiary of Continental Buyer, Inc. following the merger, ceasing to be an independent publicly traded company.

Management Comments

• Each share of the Company's Common Stock... issued and outstanding immediately prior to the Effective Time was canceled and converted into the right to receive $7.75 in cash without interest.
• Each restricted stock unit award... will automatically be canceled in consideration for the right to receive a lump sum cash payment... equal to (i) the total number of Company Shares underlying such Performant RSU multiplied by (ii) the Merger Consideration.

Industry Context

This acquisition reflects ongoing consolidation trends within the healthcare services sector, where larger entities seek to expand market share or integrate specialized services. Such mergers often aim to achieve economies of scale or enhance service offerings, providing a strategic exit for smaller or specialized companies.

Comparison to Industry Standards

• NA

Related Party Transactions

• The 3,261,675 shares disposed of were directly held by Mill Road Capital II, L.P., where Mr. Yanagi is a management committee director of its sole general partner, Mill Road Capital II GP LLC.
• Mill Road Capital Management, LLC, an affiliate of Mr. Yanagi, had the right to receive the economic benefit of the 381,835 RSUs, meaning Mr. Yanagi had no direct pecuniary interest in these specific RSUs.

Stakeholder Impact

• Shareholders: Will receive $7.75 cash per share, providing a defined return and liquidity, but will no longer hold equity in Performant Healthcare Inc. and will lose future growth potential.
• Employees: Performant Healthcare Inc. will become a subsidiary of Continental Buyer, Inc., which may lead to organizational integration efforts and potential changes in roles or structure.
• Management: The current management structure of Performant Healthcare Inc. will likely be integrated into Continental Buyer, Inc.'s operations, with potential for changes in leadership roles.

Next Steps

• Completion of the merger, resulting in Performant Healthcare Inc. becoming a wholly-owned subsidiary of Continental Buyer, Inc.
• Shareholders receiving the $7.75 cash consideration per share for their holdings.

Key Dates

Recommendation

Given the definitive merger agreement with a cash consideration of $7.75 per share, the stock is effectively trading as a 'stub' to the merger price. Investors should hold to receive the cash consideration, or sell if they wish to exit prior to the effective date, factoring in any minor arbitrage spread. There is no further upside potential beyond the merger price, and significant downside is unlikely unless the merger fails, which is not indicated in this filing.

Keywords

Performant Healthcare, PHLT, Merger, Acquisition, Continental Buyer, Eric Yanagi, Form 4, Insider Transaction, Restricted Stock Units, Cash Out